Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer with Dr. Kristen Scarpato

Our guest is Dr. Kristen Scarpato, a urologic oncologist at Vanderbilt University Medical Center. She talks with us about combination therapy for metastatic hormone-sensitive prostate cancer, or mHSPC, which is also known as metastatic castration-sensitive prostate cancer, mCSPC.  The goal of this podcast is to help educate patients and caregivers about combination therapy as a treatment option for prostate cancer so they can be more informed in making decisions with their health care team. For more information, please visit www.UrologyHealth.org and don't forget to subscribe to our free digital magazine, UrologyHealth extra® at www.urologyhealth.org/uhe. Support provided by Astellas. **** July 23, 2026